A Method of Using a Beta2-Adrenergic Receptor Agonist That Selectively Activates GS Proteins in the Treatment of Cardiovascular Disease Read more about A Method of Using a Beta2-Adrenergic Receptor Agonist That Selectively Activates GS Proteins in the Treatment of Cardiovascular Disease Patent Cooperation TreatyPCT/US1999/022712Filed on 1999-09-30
RESOLUTION AND REDUCTION OF PHYSOSTIGMINE INTERMEDIATES AND DERIVATIVES Read more about RESOLUTION AND REDUCTION OF PHYSOSTIGMINE INTERMEDIATES AND DERIVATIVES Patent Cooperation TreatyPCT/US95/15737Filed on 1995-12-05
HYDROXYALKYL CYCLODEXTRIN - ANTIFUNGAL POLYENE MACROLIDE COMPLEXES Read more about HYDROXYALKYL CYCLODEXTRIN - ANTIFUNGAL POLYENE MACROLIDE COMPLEXES US Application 07/345,928Filed on 1989-05-01
HIGHLY SELECTIVE BUTYRYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE AND DEMENTIAS Read more about HIGHLY SELECTIVE BUTYRYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE AND DEMENTIAS Patent Cooperation TreatyPCT/US1998/014063Filed on 1998-07-09
METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT Read more about METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT US Patent 6,429,232Filed on 1997-03-21
USE OF FREE (F) PSA PROPORTION OF TOTAL (T) PSA TO SCREEN FOR PROSTATE CANCER (CaP) Read more about USE OF FREE (F) PSA PROPORTION OF TOTAL (T) PSA TO SCREEN FOR PROSTATE CANCER (CaP) US Application 08/631,031Filed on 1996-04-12
METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT Read more about METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT US Patent 5,616,608Filed on 1996-04-18
ANTIPROLIFERATIVE PROTEIN Read more about ANTIPROLIFERATIVE PROTEIN US Application 08/466,762Filed on 1995-06-05
TARGETING OF LIPOSOMES TO THE BLOOD-BRAIN BARRIER Read more about TARGETING OF LIPOSOMES TO THE BLOOD-BRAIN BARRIER US Application 08/338,939Filed on 1994-11-14
RESOLUTION AND REDUCTION OF PHYSOSTIGMINE INTERMEDIATES AND DERIVATIVES Read more about RESOLUTION AND REDUCTION OF PHYSOSTIGMINE INTERMEDIATES AND DERIVATIVES US Patent 5,571,929Filed on 1994-12-07